Washington, District of Columbia 20010

  • Asthma


Little is known about how ED-based programs can help to reduce pediatric ED visits for asthma. The current study evaluated a novel intervention in which the ED itself became the site of highly individualized, comprehensive follow-up asthma care. It sought to determine if such an intervention could decrease subsequent unscheduled visits for asthma while improving asthma quality of life.

Study summary:

Prospective, randomized clinical trial of a single visit to a specialized emergency department-based asthma follow-up clinic occurring 2-15 days after emergency department care for an acute exacerbation. All patients were followed for 6 months. Analysis was by intention-to-treat with adjustment for baseline differences. Our primary hypothesis was that this intervention would decrease subsequent unscheduled visits (both to EDs and other sources of urgent care) for asthma over a six-month follow-up period. We further hypothesized that the intervention would decrease hospitalizations for asthma, improve compliance with an individualized medical plan and with trigger control, increase scheduled primary care practitioner (PCP) visits for routine asthma care, and decrease asthma symptoms while improving asthma quality of life (QOL).


Inclusion Criteria: 1. age between 12 months and 17 years, inclusive; 2. prior physician-diagnosed asthma; 3. ≥1 other unscheduled visit for asthma in the previous 6 months and/or ≥1 hospitalization for asthma in the prior 12 months; 4. a parent/guardian available for interview; 5. residence in Washington, DC or a contiguous Maryland county; and 6. requirement for ≥3 doses of nebulized albuterol in the ED at the time of enrollment. Exclusion Criteria: 1. significant medical co-morbidities affecting the cardiorespiratory system; 2. a visit to an allergist or a pulmonologist in the prior 6 months; 3. ≥2 of the following: a current written asthma medical action plan, current use of >1 controller medication, or a scheduled visit for asthma care with their PCP in the prior two weeks; 4. enrollment in another asthma research study; 5. unavailability for telephone follow-up; or 6. primary language other than English or Spanish.



Primary Contact:

Principal Investigator
Stephen J Teach, MD
Children's Research Institute

Backup Contact:


Location Contact:

Washington, District of Columbia 20010
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.